Ulan-Ude, Ulan-Ude, Russian Federation
Currently, the world is marked rise in the number of patients with liver disease. Approximately 100,000 patients hepatitis complicated by acute liver failure, with mortality in this disease reaches 70-90% despite the use of modern methods of treatment Currently, there are more than 20 concepts of this disease. In 15-20% of cases the cause of acute liver failure can not be established. Most clinicians believe that the pathogenesis of liver failure is a strong humoral and hyperimmune response, resulting in massive necrosis of liver cells. Diagnosis of liver failure based on anamnesis, clinical, biochemical and electroencephalographic changes. Traditional conservative therapy of acute liver failure in the first place based on the measures taken to address the etiological factor. Transplantation is an effective measure in acute liver failure. In the world there are a sufficient number of prognostic scales, criteria and risk factors of acute liver failure. Each of them has its own characteristics, but a unified system of prognostic estimation of arrester.
acute liver failure, etiology, pathogenesis, diagnosis, treatment, prognosis
1. .AruinLI (1998). Apoptosis and liver disease [Apoptoz i patologiya pecheni]. Ros . zhurn . gastroenterol., gepatol ., koloproktol., 8(2), 6-11.
2. GalperinEI, SemendiayevaMI, NeklyudovaEA (1978). Hepatic failure [Nedostatochnost’ pecheni], 259.
3. EremeevaLF, YampolskyAF (2010). Extracorporealtherapies in patients with hepatocellular insufficiency [Ekstrakorporal’nye metody lecheniya u patsientov s pechenochno-kletochnoy nedostatochnost’yu]. Aktual. probl. transp. med., 22 (4), 139-149.
4. ZhuravelSV (2004). Acute liver failure [Ostraya pech-enochnaya nedostatochnost’]. Сonsil. Med., 6(6), 26-31.
5. IvashkinV T, NadinskayaMY, BueverovSA (2001). Hepatic encephalopathy and methods of metabolic correction [Pechenochnaya entsefalopatiya i metody ee metabolicheskoy korrektsii]. Bol. org. pishchevar.,3, 25-27 .
6. .IsrailovVK, AytkozhinGK (2012). Modern understand-ing of liver disease and methods of treatment [Sovremen-nye predstavleniya o pechenochnoy nedostatochnosti i metody ikh lecheniya]. Vestn. KAZMNU, 1, 36-34.
7. MaevskayaMV, BueverovMV (2009). Cytokines in the pathogenesis of alcoholic hepatitis and treatment options [Tsitokiny v patogeneze alkogol’nogo gepatita i vozmozhnosti terapii]. Ros. zhurn. gastroenterol. gepatol., koloproktol., 19 (2), 14-19.
8. .MansurovHH (1987). The most important problems of modern hematology [Vazhneyshie problemy sovremen-noy gepatologii]. Klin. med., 65 (11), 59-64.
9. OnishchenkoGG (2002) The situation and measures to combat viral hepatitis in the Russian Federation [Situ-atsiya i mery bor’by s virusnymi gepatitami v Rossiyskoy Federatsii]. Med. kaf., (2), 18-22.
10. PasechnikIN , KutepovDE (2009) Hepatic impair-ment: modern methods of treatment [Pechenochnaya nedostatochnost’: sovremennye metody lecheniya], 187.
11. PlekhanovAN , ChikoteevSP, TovarshinovAI (2006). Changes in the blood levels of cytokines in the develop-ment of liver failure after operations on the liver [Izmene-nie urovney tsitokinov v krovi pri razvitii pechenochnoy nedostatochnosti posle operatsiy na pecheni]. Med. Immunol., 8(1), 61-66.
12. CherniyVI, RumyantsevSG, ShramenkoEK (2010). Fulminant hepatic failure [Ful’minantnaya pechenochnaya nedostatochnost’], 197.
13. SherlockS, DooleyJ (1999). Diseases of the liver and biliary tract [Zabolevaniya pecheni i zhelchnykh putey], 605.
14. AithalGP, WatkinsPB, AndradeRJ (2011). Case definition and phenotype standardization in drug-induced liver injury. Clin. Pharm. Therap., 89(4), 806-815.
15. Angeli P, Morando F, CavallinM (2011). Hepatore-nal syndrome. Contr. Nephrol. 7, 46-55.
16. AwadSS, SawadaS, SoldesOS (2009). Can the clearence of tumor necrosis factor alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system? ASAIO J., 45 (1), 47-49.
17. BajajJS, PinkertonSD, SanyalAJ (2012) Diag-nosis and treatment of minimal hepatic encephalopathy to prevent motor vehicle accidents: a cost-effectiveness analysis. Hepatol., 55(9), 1164-1171.
18. BantelH, Schulze-OsthoffK (2012). Mechanisms of cell death in acute liver failure. Front. Physiol., 79, 56-64.
19. BikhchandaniJ, MetcalfeM, IllouzS (2011). Extracorporeal liver perfusion system for artificial liver support across a membrane. J. Surg. Res., 171, 139-147.
20. Berghe TV, Van Loo G, Saelens X (2004) Differential signaling to apoptotic and necrotic cell death by Fas-asso-ciated death domain protein FADD. J. Biol. Chem., 4, 49-53.
21. Bernal W, Auzinger G, Dhawan A (2010) Acute liver failure. Lancet, 376, 190-201.
22. Bramhall SR (2009) Aetiology and outcome of acute liver failure. HPB (Oxford), 11 (5), 429-434.
23. Butterworth RF (2012) Reprint of: Neuroin-flammation in acute liver failure: Mechanisms and novel therapeutic targets. Neurochem. Int.,60, 715-722.
24. Canbay A, Tacke F, Hadem J (2011) Acute liver failure: a life-threatening disease. Dtsch. Arztebl. Int., 108 (42), 714-720.
25. Chen J, Lin S, Zhu YY (2016) Liver to abdominal area ratio in prognosis prediction in alcohol-induced acute-on-chronic liver failure // Zhonghua Yi. Xue Za Zhi., 96 (10), 801-806.
26. Frei P, Minder EI, Corti N (2012) Liver Transplan-tation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria. Case Rep. Gastroenterol., 6 (1), 190-196.
27. Hong YS, Sinn DN, Gwak GY (2016). Charac-teristics and outcomes of chronic liver disease. World J. Gastroenterol., 22 (14), 3785-3792.
28. KarkhanisJ, LeeWM, BrownRS (2008). Steroid use in drug induced and cryptogenic causes of acute liver failure. AASLD, 48 (4), 446-447.
29. Kobashi-MargáinRA, Gavilanes-EspinarJG,Gutiérrez-GrobeY (2011). Albumin dialysis with mo-lecular adsorbent recirculating system (MARS) for the treatment of hepatic encephalopathy in liver failure. Ann. Hepatol., 5, 70-76.
30. KumarasenaRS, NiriellaMA, RanawakaCK (2016). Predi сting acute liver failure in denque infection. Ceylon. Med. J., 61 (1), 35-36.
31. LalemanW, VerbekeL (2011) Acute-on-chronic liver failure: current concepts on definition, pathogen-esis, clinical manifestations and potential therapeutic interventions. Exp. Rev. Gastroenter. Hepatol., 5(4),523-537.
32. LefkowitchJH (2016). The pathology of acute liver failure. Ady. Anat. Pathol., 23 (3), 144-158.
33. MochidaS, TakikawaY, NakayamaN (2011). Diagnostic criteria of acute liver failure. Hepatol. Res., 41 (9), 805-812.
34. MoreauR (2016). Acute-on-chronic liver failure: a new syndrome in cirrhosis. Clin. Mol. Hepatol., 22 (1), 1-6.
35. O’GradyJG (2005). Acute liver failure. Postgrad. Med. J., 81, 148-154.
36. PathikondaM, MunozS (2010). Acute Liver Fail-ure. Ann. of Hepatol., 9(1), 7-14.
37. PatelD, McPhailMJ, CobboldJF (2012).Hepatic encephalopathy. Br. J. Hosp. Med. (Lond).,73(2), 79-85.
38. Paugam-BurtzC, WendonJ (2012). Case Scenario: Postoperative Liver Failure after Liver Resection in a Cir-rhotic Patient. Anesthesiol., 116, 705-711.
39. RahimiRS, RockeyDC (2016). Acute on chronic liver failure: definitions, treatments and outcomes. Curr. Opin. Gastroenterol., 32 (3), 172-181.
40. SlackA, WendonJ (2011). Acute liver failure. Clin. Med., 11(3), 254-258.
41. StutchfieldBM, SimpsonK, WigmoreSJ (2011). Systematic review and meta-analysis of survival following extracorporeal liver support. Br. J. Surg., 98, 623-631.
42. SundaramV, ShaikhOS (2011). Acute liver failure: current practice and recent advances. Gastroenterol.Clin. North Am., 40 (3), 523-539.
43. ZhangJ, GaoS, DuanZ (2016). Overview on acute-on-chronic liver failure. Front., 10(1), 1-17
